TSHA
Taysha Gene Therapies Inc.
NASDAQ · Healthcare
Taysha Gene Therapies Inc. annual/quarterly net income history and growth rate from 2022 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Taysha Gene Therapies Inc. net income for the quarter ending March 31, 2026 was -42.4 M, a 96.99% increase year-over-year.
- Taysha Gene Therapies Inc. net income for the twelve months ending March 31, 2026 was -123.6 M, a 34.14% decrease year-over-year.
- Taysha Gene Therapies Inc. annual net income for 2025 was -109.0 M, a 22.06% increase from 2024.
- Taysha Gene Therapies Inc. annual net income for 2024 was -89.3 M, a 19.96% decrease from 2023.
- Taysha Gene Therapies Inc. annual net income for 2023 was -111.6 M, a 32.80% decrease from 2022.
- Taysha Gene Therapies Inc. annual net income for 2022 was -166.0 M.
Net Income
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %